CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 9 of 48

Rheumatology (Oxford)

Briefs 321–360 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Long-term safety and efficacy of tocilizumab in adult-onset Still’s disease: open-label, long-term extension of the phase III trial

    Research articleAutoinflammatory & rare

  2. Rheumatology (Oxford)

    Treating-to-target: remission and low disease activity in systemic lupus erythematosus versus rheumatoid arthritis

    Cohort studyRA

  3. Rheumatology (Oxford)

    Validation of the revised definition of lupus low disease activity in patients with SLE

    Cohort studyLupus & APS

  4. Rheumatology (Oxford)

    Evaluation of a screening algorithm to detect systemic sclerosis-related myopathy

    Cohort studySystemic sclerosis

  5. Rheumatology (Oxford)

    Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDs

    Research articleSpondyloarthritis & PsA

  6. Rheumatology (Oxford)

    Development of a tool to map SSc pain sources, characteristics and management experiences: the SPIN Pain Assessment Tool

    Research articleSystemic sclerosis

  7. Rheumatology (Oxford)

    Effectiveness and safety of high-intensity exercise in rheumatic diseases—friend or foe? A systematic review

    Meta-analysisAcross diseases

  8. Rheumatology (Oxford)

    Prediction of foetal atrioventricular conduction using maternal disease, treatment and anti-Ro/La autoantibody levels

    Cohort studySjögren's & overlap

  9. Rheumatology (Oxford)

    Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort study

    Cohort studyLupus & APS

  10. Rheumatology (Oxford)

    Heterogeneity in the association of genetic risk for RA and resultant RA phenotypes

    Cohort studyRA

  11. Rheumatology (Oxford)

    Beyond the surface: soluble SIGLEC-1 as a clinically applicable type I IFN biomarker

    Diagnostic or prognostic studyLupus & APS

  12. Rheumatology (Oxford)

    Characterization of latent allergen profile and association with clinical features in patients with IgG4-related disease

    Cross-sectional studyAutoinflammatory & rare

  13. Rheumatology (Oxford)

    Cytokine/chemokine profiles in rheumatoid arthritis patients who failed Boolean remission solely due to elevated patient global assessment

    Cohort studyRA

  14. Rheumatology (Oxford)

    Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients

    Cohort studyRA

  15. Rheumatology (Oxford)

    Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  16. Rheumatology (Oxford)

    Addressing cohort reliance in rare diseases literature: a scoping review of myositis research

    Research articleMyositis

  17. Rheumatology (Oxford)

    A head-to-head comparison of TNF-α inhibitors as the first biologic treatment of rheumatoid arthritis

    Cohort studyRA

  18. Rheumatology (Oxford)

    Tumor necrosis factor alpha inhibitors in Behçet’s disease: indications, efficacy, and safety of two widely used agents

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Greyscale, colour Doppler and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort

    Cross-sectional studyAutoinflammatory & rare

  20. Rheumatology (Oxford)

    The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren’s disease

    Mechanistic studyMyositis

  21. Rheumatology (Oxford)

    Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study

    Cohort studySystemic sclerosis

  22. Rheumatology (Oxford)

    Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

    Cohort studyVasculitis & PMR

  23. Rheumatology (Oxford)

    Work-related physical strain as novel risk factor for the severity of joint inflammation at diagnosis of anti-citrullinated protein antibodies–positive rheumatoid arthritis

    Cohort studyRA

  24. Rheumatology (Oxford)

    Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis

    Cohort studyMyositis

  25. Rheumatology (Oxford)

    Relationship between spinal lesions related to axial spondyloarthritis and degenerative spinal lesions: 10-year follow-up of the DESIR cohort

    Cohort studySpondyloarthritis & PsA

  26. Rheumatology (Oxford)

    Genetic susceptibility, walking activity and the risk of incident gout

    Cohort studyGout & crystals

  27. Rheumatology (Oxford)

    Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry

    Cohort studyVasculitis & PMR

  28. Rheumatology (Oxford)

    Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case–control study

    Cohort studyVasculitis & PMR

  29. Rheumatology (Oxford)

    An interpretable metabolomic-driven machine learning model for early prediction of knee structural OA progression

    Diagnostic or prognostic studyOsteoarthritis

  30. Rheumatology (Oxford)

    Work participation and work disability in Belgian patients with systemic sclerosis

    Cross-sectional studySystemic sclerosis

  31. Rheumatology (Oxford)

    Gut microbiome–metabolome dysregulation in systemic sclerosis: a multi-omics study

    Case-control studySystemic sclerosis

  32. Rheumatology (Oxford)

    Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre–multidisciplinary retrospective study

    Cohort studyLupus & APS

  33. Rheumatology (Oxford)

    Results from a pilot study of dusquetide for the treatment of aphthous ulcers associated with Behçet's syndrome

    Research articleVasculitis & PMR

  34. Rheumatology (Oxford)

    Diffuse alveolar haemorrhage in antiphospholipid syndrome: a French series of 26 patients

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome

    Cohort studyLupus & APS

  36. Rheumatology (Oxford)

    Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry

    Cross-sectional studySystemic sclerosis

  37. Rheumatology (Oxford)

    Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy

    Case-control studyGout & crystals

  38. Rheumatology (Oxford)

    Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

    Cohort studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up

    Cohort studyLupus & APS

  40. Rheumatology (Oxford)

    Prevalence, clinical associations and outcomes of pericarditis in systemic lupus erythematosus: insights from the University of Toronto Lupus Clinic

    Cohort studyLupus & APS

All 1,905 Briefs in ExploreShowing Briefs 321–360 of 1,905, newest first